{
  "docId": "019dd923-622c-750b-8b9b-a077f08347fa",
  "docSlug": "4934d687cb38",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-10-30 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 22,
  "pageCount": 39,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a direct quote from a U.S. Attorney to establish credibility and frame the villain.",
  "elementsJson": [
    "headline_text",
    "quote_block",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-a077f08347fa/22",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.37
      },
      "kind": "list",
      "text": "Novartis paid kickbacks to specialty pharmacies to induce them to recommend Novartis medications and increase sales of Novartis drugs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b82e45d-7888-4083-8f47-dc058e3485c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.92,
        "x": 0.04,
        "y": 0.71
      },
      "kind": "list",
      "text": "One of the pharmacies gave biased advice to encourage the use of Novartis drugs, and simultaneously understated serious, potentially life-threatening, side effects, using talking points that were approved by Novartis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "304515d9-6f60-42f9-8ba9-2838e679dfb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.92,
        "x": 0.04,
        "y": 0.57
      },
      "kind": "list",
      "text": "The pharmacies actively tried to switch patients from competitor drugs to Novartis drugs, and the payments they received from Novartis depended on the success of these “conversion” efforts",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ffbfe3f-08cf-4176-9ab8-63847e7d2376",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.47
      },
      "kind": "list",
      "text": "Novartis only contracted with pharmacies that represented that they would be able to convert patients to Novartis drugs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aea801e1-6440-4ffd-b184-3c10e9116836",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "quote",
      "text": "As alleged, using the lure of kickbacks disguised as rebates, Novartis co-opted the independence of certain pharmacists and turned them into salespeople for one of its drugs. - Manhattan U.S. Attorney Preet Bharara, April 23, 2013",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85fbde2b-acce-4a9e-adf5-165458b85927",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"As alleged, using the lure of kickbacks disguised as rebates, Novartis co-opted the independence of certain pharmacists and turned them into salespeople for one of its drugs.\" — Manhattan U.S. Attorney Preet Bharara, April 23, 2013",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-70f7-7334-b228-2e019b0ac13c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.58,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Novartis: A Recent Case Study Allegations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a47920d5-6791-4e39-a060-7c53c68a7a71",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "5964ce81-3f49-43fc-aafb-88dd2f27c680",
      "evidence": "The slide explicitly frames Novartis as the antagonist through legal allegations and a U.S. Attorney quote.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}